Eidos Therapeutics Inc (EIDX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO, CA 94104

Eidos Therapeutics, Inc. operates as a bio-pharmaceutical company. The Company discovers and develops novel oral therapy for the treatment of diseases. Eidos Therapeutics serves clients in the State of California.

Data as of 2021-02-06 11:04:05 -0500
Market Cap0 Shares Outstanding38.873 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-43.81 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from EIDX instead.

View recent insider trading info

Funds Holding EIDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EIDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROHLEN DOUGLAS

  • Director
No longer subject to file 2021-01-26 1

HOOPER SUZANNE SAWOCHKA

  • Director
No longer subject to file 2021-01-26 1

LIS WILLIAM

  • Director
No longer subject to file 2021-01-26 1

SATVAT ALI J.

  • Director
No longer subject to file 2021-01-26 1

FOX JONATHAN C SEE REMARKS

  • Officer
No longer subject to file 2021-01-26 1

VALLE FRANCO SENIOR VICE PRESIDENT, FINANCE

  • Officer
No longer subject to file 2021-01-26 3

SINHA UMA CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2021-01-26 4

BRIDGEBIO PHARMA, INC.

  • 10% Owner
1,000 2021-01-26 1

TURTLE CAMERON CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2021-01-26 4

AGUIAR ERIC

  • Director
0 2020-05-27 0

SHAH RAJEEV M.

  • Director
0 2020-05-27 0

SIU CHRISTINE CFO AND SECRETARY

  • Officer
36,470 2019-12-09 0

KUMAR NEIL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
24,575,501 2019-07-03 0

LIS WILLIAM

LIS WILLIAM

  • Director
0 2018-12-04 1

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
2,162,671 2018-06-22 0

HUH HOYOUNG

  • Director
0 2018-06-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments